Stock NOTV INOTIV, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Inotiv, Inc.

Equities

NOTV

US45783Q1004

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
3.84 USD +2.67% Intraday chart for Inotiv, Inc. -20.82% +4.63%
Mar. 19 Inotiv, Inc. Elects Michael J. Harrington as Class III Member of the Board CI
Feb. 12 North American Morning Briefing : Stock Futures -2- DJ

Evolution of the average Target Price on Inotiv, Inc.

Price target over the last 5 years

History of analyst recommendation changes

deb823390cedd8dba.sGWILACl_j-WmVAGQgNF7brpMdU2VLeumHVI_FFaR6s.6FbSZWyVkF394xF_EHEhgeiueoYADsL93Q19vhcoI5LjE-JOMs-vaP7RJw~997559b930d318dfa428c7ca9eb33147

Analyst Recommendations on Inotiv, Inc.

Jefferies Upgrades Inotiv to Buy Rating From Hold, Adjusts Price Target to $11.50 From $3 MT
Jefferies Adjusts Inotiv Price Target to $3 From $7.25, Maintains Hold Rating MT
Craig-Hallum Adjusts Price Target on Inotiv to $25 From $34, Maintains Buy Rating MT
Wells Fargo Initiates Coverage on Inotiv with Overweight Rating, $9 Price Target MT
Jefferies Downgrades Inotiv to Hold From Buy, Adjusts Price Target to $8 From $10 MT
Lake Street Upgrades Inotiv to Buy From Hold, Adjusts Price Target to $10 From $4 MT
Wall Street Set to Open Higher as Investors Await Inflation Data, Fed Rate Decision in Coming Days MT
Lake Street Downgrades Inotiv to Hold From Buy, Adjusts Price Target to $7 From $60 MT
Jefferies Starts Inotiv at Buy With $27 Price Target MT
Lake Street Raises Inotiv's Price Target to $60 From $50, Maintains Buy Rating MT
Lake Street Adjusts Inotiv's Price Target to $50 from $75, Maintains Buy Rating MT
Craig-Hallum Adjusts Inotiv's Price Target to $64 From $57, Reiterates Buy Rating MT
Inotiv Shares Soar After Lake Street Initiates Coverage at Buy MT
Lake Street Initiates Inotiv at Buy, Sets Price Target to $60 MT
Inotiv : Shares Rise After Craig-Hallum Starts Coverage With Buy Rating MT
INOTIV : Craig-Hallum Starts Inotiv at Buy with $45 Price Target MT
BIOANALYTICAL : Colliers Securities Starts Bioanalytical Systems at Buy With $17 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.84 USD
Average target price
15.5 USD
Spread / Average Target
+303.65%
High Price Target
25 USD
Spread / Highest target
+551.04%
Low Price Target
10 USD
Spread / Lowest Target
+160.42%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Inotiv, Inc.

Jefferies & Co.
Craig-Hallum
Wells Fargo Securities
Lake Street

Ratings for Inotiv, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NOTV Stock
  4. Consensus Inotiv, Inc.